[Mechanism of action of orally-applied proteolytic enzymes: mechanistic and therapeutic aspects].
Birkenmeier
G
G
Institut für Biochemie, Universität Leipzig, Leipzig. Gerd.Birkenmeier@medizin.uni-leipzig.de
D000284:Administration, Oral; D000544:Alzheimer Disease / Q000473:pathology / Q000517:prevention & control*; D016229:Amyloid beta-Peptides / Q000378:metabolism; D017951:Antigen Presentation / Q000502:physiology; D001777:Blood Coagulation / Q000502:physiology; D003167:Complement Activation / Q000502:physiology; D016207:Cytokines / Q000378:metabolism; D005342:Fibrinolysis / Q000502:physiology; D006801:Humans; D007109:Immunity / Q000187:drug effects / Q000502:physiology*; D036341:Intercellular Signaling Peptides and Proteins / Q000378:metabolism; D009369:Neoplasms / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D010447:Peptide Hydrolases / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D011480:Protease Inhibitors / Q000494:pharmacology; D053773:Transforming Growth Factor beta1 / Q000037:antagonists & inhibitors; D000511:alpha-Macroglobulins / Q000494:pharmacology / Q000502:physiology*
D016229:Amyloid beta-Peptides; D016207:Cytokines; D036341:Intercellular Signaling Peptides and Proteins; D011480:Protease Inhibitors; D053773:Transforming Growth Factor beta1; D000511:alpha-Macroglobulins; D010447:Peptide Hydrolases